Cardiac resynchronization therapy: from treatment to prevention.
Résumé
This editorial refers to 'Response to preventive cardiac resynchronization therapy in patients with ischaemic and non-ischaemic cardiomyopathy in MADIT-CRT', by A. Barsheshet et al. doi:10.1093/eurheartj/ehq407, 'Timedependent benefit of preventive cardiac resynchronization therapy after myocardial infarction', by A. Barsheshet et al. doi:10.1093/eurheartj/ehq392, and 'Cost-effectiveness of cardiac resyncronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)', by C. Linde et al. doi:10.1093/eurheartj/ehq408.